Customer matched zone "Lagos Delivery Options"
Sort by:
73873–73888 of 388805 Results
-
-
-
These tablets are typically taken orally, with dosage instructions provided by a healthcare professional. The dosage may vary depending on the severity of the condition and individual response to treatment.Sku: 1720031254-2082
Cipram 20mg tablets 28?s
₦7,280.00 -
-
Cipram Tablets SpecificationRequires Prescription (YES/NO)YesGenericsCitalopram HBrUsed ForDepressionHow it worksThe mechanism of action of citalopram HBr as an antidepressant is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT). In vitro and in vivo studies in animals suggest that citalopram is a highly selective serotonin reuptake inhibitor (SSRI) with minimal effects on norepinephrine (NE) and dopamine (DA) neuronal reuptake. Tolerance to the inhibition of 5-HT uptake is not induced by long-term (14-day) treatment of rats with citalopram. Citalopram is a racemic mixture (50/50), and the inhibition of 5-HT reuptake by citalopram is primarily due to the (S)-enantiomer.Cipram Tablets Usage And SafetyDosageCitalopram HBrSide EffectsGI upset , tremor , somnolence , dry mouth , anorexia , agitation , decreased lipid , anxiety , confusion , sleep disorders , tinnitus , yawning , pruritis , impotence , amnesia , apathy , increases salivation , increased sweating , abnormal accommodation. Hyponatraemia , bleeding disorders , serotonin syndrome .Drug InteractionsMAOIs, lithium , tryptophan , pimozide , other neuroleptics , St.John's wort, other SSRIs , SNRIs , 5HT1 agonists , triptans , other serotonergic drugs , linezolid , drugs that prolong QT interval , tramadol , anticoagulants , NSAIDs and other drugs affecting plastelet function . CYP2D6 substrates (e.g., metoprolol) , CYP2C19 inhibitors (e.g. PPIs) , cimetidine , drugs that reduce seizure threshold . Drugs that induce hypokalaemia or hypomagnesaemia. Alcohol.IndicationIt is used in depressive disorders (endogenous and non-endogenous).When not to UseHyersensitive to any of the ingredients.Cipram Tablets PrecautionsPrecautionAll patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases.Cipram Tablets WarningsWarning 1Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of this medicine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need.Warning 2Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior.Warning 3Families and caregivers should be advised of the need for close observation and communication with the prescriber. It is not approved for use in pediatric patients.Cipram Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.Sku: 1716677311-1547
Cipram Tablets 20Mg (1 Box = 1 Strip)(1 Strip = 14 Tablets)
₦154,014.00 -
-
-
SaleCipran 40 mgLevomilnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of Major Depressive Disorder (MDD) in adults.Limitation of Use: Levomilnacipran is not approved for the management of fibromyalgia. The efficacy and safety of Levomilnacipran for the management of fibromyalgia have not been established.Dosage of Cipran 40 mgRecommended dose: 40 mg to 120 mg once daily with or without food. Initiate dose at 20 mg once daily for 2 days and then increase to 40 mg once daily. Based on efficacy and tolerability, increase dose in increments of 40 mg at intervals of 2 or more days. The maximum recommended dose is 120 mg once daily. Take capsules whole; do not open, chew or crush.Renal Impairment: Do not exceed 80 mg once daily for moderate impairment. Do not exceed 40 mg once daily for severe renal impairment.Discontinuation: Reduce dose gradually whenever possible.Interaction of Cipran 40 mgStrong CYP3A4 inhibitors such as ketoconazole: Do not exceed 80 mg once daily.ContraindicationsHypersensitivity to levomilnacipran, milnacipran HCl or to any excipient in the formulation.The use of MAOIs intended to treat psychiatric disorders with Levomilnacipran or within 7 days of stopping treatment with Levomilnacipran is contraindicated because of an increased risk of serotonin syndrome. The use of Levomilnacipran within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.Starting Levomilnacipran in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.Side Effects of Cipran 40 mg Hypersensitivity Suicidal Thoughts and Behaviors in Adolescents and Young Adults? Serotonin Syndrome Elevated Blood Pressure Elevated Heart Rate Increased Risk of Bleeding Angle Closure Glaucoma Urinary Hesitation or Retention Activation of Mania/Hypomania Seizure Discontinuation Syndrome Hyponatremia Storage ConditionsKeep below 30?C temperature, away from light & moisture. Keep out of the reach of children.Drug ClassesSerotonin-norepinephrine reuptake inhibitor (SNRI)Mode Of ActionThe exact mechanism of the antidepressant action of levomilnacipran is unknown, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of reuptake at serotonin and norepinephrine transporters. Non-clinical studies have shown that levomilnacipran is a potent and selective serotonin and norepinephrine reuptake inhibitor (SNRI).Levomilnacipran binds with high affinity to the human serotonin (5-HT) and norepinephrine (NE) transporters (Ki = 11 and 91 nM, respectively) and potently inhibits 5-HT and NE reuptake (IC50 = 16-19 and 11 nM, respectively). Levomilnacipran lacks significant affinity for any other receptors, ion channels or transporters tested in vitro, including serotonergic (5HT1-7), ?- and ?-adrenergic, muscarinic, or histaminergic receptors and Ca2+, Na+, K+ or Cl- channels. Levomilnacipran did not inhibit monoamine oxidase (MAO).PregnancyPregnancy: Third trimester use may increase risk for symptoms of poor adaptation (respiratory distress, temperature instability, feeding difficulty, hypotonia, tremor, irritability) in the neonate.Pediatric UsesPediatric Use: Clinical studies on the use of Levomilnacipran in pediatric patients have not been conducted; therefore, the safety and effectiveness of Levomilnacipran in the pediatric population have not been established. Levomilnacipran is not approved for use in pediatric patients.Geriatric Use: No dose adjustment is recommended on the basis of age. In a multiple-dose clinical pharmacokinetic study, elderly subjects (> 65 years) had a slightly higher exposure (C max by 24% and AUC by 26%) of levomilnacipran than younger subjects (18-45 years). Of the total number of subjects in the 8-week clinical studies of Levomilnacipran, 2.8% of patients were age 65 or older. Because levomilnacipran is predominately excreted by the kidney, renal clearance of levomilnacipran should be considered when determining the dose. SSRIs and SNRIs, including Levomilnacipran, have been associated with cases of clinically significant hyponatremia in elderly patients, who may be at greater risk for this adverse event.Hepatic Impairment: Hepatic elimination of levomilnacipran is low. Dose adjustment is not recommended in subjects with mild (Child-Pugh score of 1-6), moderate (Child-Pugh score of 7-9), or severe (Child-Pugh score of 10-13) hepatic impairment.Renal Impairment: Renal excretion plays a predominant role in the elimination of levomilnacipran. Dose adjustment is not recommended for patients with mild (creatinine clearance of 60-89 ml/min) renal impairment. Dosing adjustment is recommended for patients with moderate (creatinine clearance of 30-59 ml/min) or severe (creatinine clearance of 15-29 ml/min) renal impairment. Levomilnacipran is not recommended for patients with end stage renal disease.Sku: 1736094243-645
Cipran40 mg
₦5,940.00Original price was: ₦5,940.00.₦5,346.00Current price is: ₦5,346.00.₦5,940.00Original price was: ₦5,940.00.₦5,346.00Current price is: ₦5,346.00. Add to basket Quick View -
CIPRAPRO 10 MG ( ESCITALOPRAM ) 10 FILM-COATED TABLETSSku: 1720435364-758
CIPRAPRO 10 MG ( ESCITALOPRAM ) 10 FILM-COATED TABLETS
₦450.00 -
CIPRAPRO 10 MG ( ESCITALOPRAM ) 30 FILM-COATED TABLETSSku: 1720435361-757
CIPRAPRO 10 MG ( ESCITALOPRAM ) 30 FILM-COATED TABLETS
₦1,800.00 -
-
CIPRICOM CIPROFLOXACIN EYE/EAR DROP 5MLSku: 1726858358-3231
CIPRICOM CIPROFLOXACIN EYE/EAR DROP 5ML
₦2,038.40 -
Ciprin Tablets SpecificationRequires Prescription (YES/NO)YesGenericsCiprofloxacin HClUsed ForBacterial InfectionHow it worksIt acts via inhibition of bacterial DNA gyrase (topoisomerase, which is essential in the reproduction of bacterial DNA), ultimately resulting in interference with DNA function. Ciprofloxacin is highly active against a wide range of Gram-positive and Gram-negative organisms and has shown activity against some anaerobes.Ciprin Tablets Usage And SafetyDosageCiprofloxacin HClSide EffectsNausea, Diarrhoea , Mycotic superinfections, Eosinophilia, Anorexia, Psychomotor hyperactivity / agitation, Headache, Dizziness, Sleep disorders, Taste disorders, Vomiting, Gastrointestinal and abdominal pains, Dyspepsia, Flatulence, Increase in transaminases, Increased bilirubin, Rash, Pruritus, Urticaria, Musculoskeletal pain (e.g. extremity pain, back pain, chest pain), Arthralgia, Renal impairment, Asthenia, Fever, Increase in blood alkaline phosphatase.Drug InteractionsTheophylline, clozapine, tacrine, ropinirole, tizanidine, duloxetine , Chelation complex formulation like , calcium, magnesium, aluminum or iron), polymeric phosphate binders (e.g., sevelamer), sucralfate or antacids and highly buffered drugs (e.g., didanosine ) , caffeine or pentoxifylline (oxpentifylline) , Phenytoin , Glyburide/Glibenclimide , Warfarin , Probencid , Methotrexate , Metoclopramide , Omeprazole , Cyclosporin , Sildenafil.IndicationIt is used to treat : ? Lower respiratory tract infections due to Gram-negative bacteria? Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria? Urinary tract infections? Genital tract infectionsWhen not to UseCiprofloxacin is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, any member of the quinolone class of antimicrobial agents or any of the product components. - Concomitant administration with tizanidine is contraindicated.Ciprin Tablets PrecautionsPrecautionCases of hepatic necrosis and life-threatening hepatic failure have been reported with ciprofloxacin. In the event of any signs and symptoms of hepatic disease (such as anorexia, jaundice, dark urine, pruritus, or tender abdomen), treatment should be discontinued.Ciprin Tablets WarningsWarning 1Hypersensitivity and allergic reactions, including anaphylaxis and anaphylactoid reactions, may occur following a single dose and may be life-threatening.If such reaction occurs, ciprofloxacin should be discontinued and an adequate medical treatment is required.Warning 2Ciprofloxacin should be discontinued in patients experiencing symptoms of neuropathy, including pain, burning, tingling, numbness, and/or weakness in order to prevent the development of an irreversible condition.Warning 3Patients with a family history of actual defects in glucose-6-phosphate dehydrogenase activity are prone to hemolytic reactions with quinolones, and so ciprofloxacin should be used with caution in these patients.Ciprin Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.Sku: 1716671841-822
Ciprin Tablets 250Mg (1 Box = 1 Strip)(1 Strip = 10 Tablets)
₦2,518.00 -
Ciprofloxacin is used to treat or prevent certain infections caused by bacteria such as pneumonia; gonorrhea (a sexually transmitted disease); typhoid fever (a serious infection that is common in developing countries); infectious diarrhea (infections that cause severe diarrhea); and infections of the skin, bone, joint, etc.Sku: 1714334979-1903
CIPRINOL 500MG TABS 10?S
₦100.00 -